Edda Haberlandt

4.7k total citations
89 papers, 1.7k citations indexed

About

Edda Haberlandt is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Edda Haberlandt has authored 89 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 30 papers in Pediatrics, Perinatology and Child Health and 21 papers in Molecular Biology. Recurrent topics in Edda Haberlandt's work include Epilepsy research and treatment (33 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Metabolism and Genetic Disorders (18 papers). Edda Haberlandt is often cited by papers focused on Epilepsy research and treatment (33 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Metabolism and Genetic Disorders (18 papers). Edda Haberlandt collaborates with scholars based in Austria, Germany and Switzerland. Edda Haberlandt's co-authors include Sabine Scholl‐Bürgi, Daniela Karall, Kevin Rostásy, Markus Rauchenzauner, Gerhard Luef, Gerhard Kluger, Thomas Bast, Eugen Trinka, Iris Unterberger and Wolfgang Högler and has published in prestigious journals such as Brain, Neurology and PEDIATRICS.

In The Last Decade

Edda Haberlandt

82 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edda Haberlandt Austria 25 641 477 371 288 261 89 1.7k
Tae‐Sung Ko South Korea 24 999 1.6× 597 1.3× 216 0.6× 232 0.8× 162 0.6× 116 1.7k
Friedrich Ebinger Germany 24 505 0.8× 333 0.7× 645 1.7× 255 0.9× 284 1.1× 74 1.9k
Bernhard Schmitt Switzerland 31 733 1.1× 594 1.2× 618 1.7× 377 1.3× 431 1.7× 82 2.3k
Willem F. Arts Netherlands 26 1.1k 1.6× 893 1.9× 313 0.8× 354 1.2× 134 0.5× 47 1.9k
Hadassa Goldberg‐Stern Israel 23 790 1.2× 388 0.8× 378 1.0× 350 1.2× 108 0.4× 51 1.6k
Mi‐Sun Yum South Korea 22 637 1.0× 386 0.8× 256 0.7× 232 0.8× 78 0.3× 110 1.4k
Olivier Dulac France 22 797 1.2× 553 1.2× 574 1.5× 232 0.8× 389 1.5× 78 2.0k
Francesca Darra Italy 24 819 1.3× 440 0.9× 365 1.0× 522 1.8× 117 0.4× 86 1.6k
Marina Trivisano Italy 25 875 1.4× 406 0.9× 460 1.2× 644 2.2× 129 0.5× 104 1.7k
Suvasini Sharma India 21 699 1.1× 442 0.9× 279 0.8× 227 0.8× 567 2.2× 177 1.9k

Countries citing papers authored by Edda Haberlandt

Since Specialization
Citations

This map shows the geographic impact of Edda Haberlandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edda Haberlandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edda Haberlandt more than expected).

Fields of papers citing papers by Edda Haberlandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edda Haberlandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edda Haberlandt. The network helps show where Edda Haberlandt may publish in the future.

Co-authorship network of co-authors of Edda Haberlandt

This figure shows the co-authorship network connecting the top 25 collaborators of Edda Haberlandt. A scholar is included among the top collaborators of Edda Haberlandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edda Haberlandt. Edda Haberlandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, Clemens, Ekaterina Pataraia, Edda Haberlandt, et al.. (2025). Attitudes towards epilepsy in the Austrian general population: Predictors and national trends. Epilepsy & Behavior. 165. 110291–110291. 1 indexed citations
2.
Schmitt, Friedhelm C., Edda Haberlandt, Stephan Rüegg, & Adam Strzelczyk. (2024). Hundert Jahre EEG, 6 Monate neue Leitlinie „Erster epileptischer Anfall und Epilepsien im Erwachsenenalter“ und 1 Jahr Clinical Epileptology. 37(2). 99–102.
3.
Korinthenberg, Rudolf, Thomas Bast, Edda Haberlandt, et al.. (2024). Efficacy and safety of corticosteroids and ACTH in epileptic syndromes beyond Infantile Epileptic Spasms Syndrome (IESS): A systematic review and meta‐analysis. Epilepsia. 65(5). 1155–1175. 5 indexed citations
4.
Azizi, Amedeo A., Christian Rauscher, Robert Birnbacher, et al.. (2024). Publisher Erratum: Neurofibromatose Typ 1: Vorsorgebogen für Kinder und Jugendliche in Österreich. Monatsschrift Kinderheilkunde. 174(S1). 61–62. 1 indexed citations
5.
Ganahl, Kristin, et al.. (2023). Parental anxiety and depression are associated with adverse mental health in children with special needs during the COVID-19 pandemic. Frontiers in Public Health. 11. 1254277–1254277. 6 indexed citations
8.
Haberlandt, Edda, et al.. (2016). Ketogene Ernährungstherapie – Formen und Anwendungsgebiete. Pädiatrie & Pädologie. 51(4). 152–155. 1 indexed citations
9.
Haberlandt, Edda, et al.. (2013). Matrix-metalloproteinases and proinflammatory cytokines in children with febrile convulsions and epilepsy—Cause or consequence?. Epilepsy Research. 105(1-2). 225–228. 3 indexed citations
10.
Kuchukhidze, Giorgi, Florian Koppelstaetter, Iris Unterberger, et al.. (2013). Midbrain–hindbrain malformations in patients with malformations of cortical development and epilepsy: A series of 220 patients. Epilepsy Research. 106(1-2). 181–190. 9 indexed citations
11.
Haberlandt, Edda, Matthias Baumann, Christine Fauth, et al.. (2013). Chromosomal microaberrations in patients with epilepsy, intellectual disability, and congenital anomalies. Clinical Genetics. 86(4). 361–366. 8 indexed citations
12.
Haberlandt, Edda, et al.. (2012). Microdeletion 19p13.2 in an almost 5‐year‐old boy. American Journal of Medical Genetics Part A. 158A(5). 1190–1194. 7 indexed citations
13.
Kluger, Gerhard, Edda Haberlandt, Gerhard Kurlemann, et al.. (2010). First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy. Epilepsy & Behavior. 17(4). 546–548. 44 indexed citations
14.
Kaufmann, Liane, Nikola Zieren, Daniela Karall, et al.. (2010). Predictive validity of attentional functions in differentiating children with and without ADHD: a componential analysis. Developmental Medicine & Child Neurology. 52(4). 371–378. 38 indexed citations
15.
Scholl‐Bürgi, Sabine, Edda Haberlandt, T. Gotwald, et al.. (2009). Stroke-Like Episodes in Propionic Acidemia Caused by Central Focal Metabolic Decompensation. Neuropediatrics. 40(2). 76–81. 24 indexed citations
16.
Haberlandt, Edda, et al.. (2008). Levetiractam in the treatment of two children with myoclonic status epilepticus. European Journal of Paediatric Neurology. 13(6). 546–549. 11 indexed citations
17.
Rauchenzauner, Markus, Edda Haberlandt, Martin Ortler, et al.. (2008). N-terminal pro-brain natriuretic peptide (NT-proBNP) release in children with vagus nerve stimulation. Journal of Neurology. 255(7). 980–985. 2 indexed citations
18.
Rauchenzauner, Markus, Edda Haberlandt, Stefanie Foerster, et al.. (2006). Brain‐type Natriuretic Peptide Secretion Following Febrile and Afebrile Seizures—A New Marker in Childhood Epilepsy?. Epilepsia. 48(1). 101–106. 22 indexed citations
19.
Kotzot, Dieter, et al.. (2005). Del(18)(q12.2q21.1) caused by a paternal sister chromatid rearrangement in a developmentally delayed girl. American Journal of Medical Genetics Part A. 135A(3). 304–307. 11 indexed citations
20.
Trinka, Eugen, Iris Unterberger, Josef M. Unterrainer, et al.. (2004). Long-term prognosis for childhood and juvenile absence epilepsy. Journal of Neurology. 251(10). 1235–1241. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026